Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Conrad Cairo Hotel

25 nov 2024 6:00 p.m. - 27 nov 2024 6:00 p.m.

1191 Nile Corniche, Cairo, 11221, Egypt

Middle East and North Africa Conference (MENA)

Parallel Session 7A: The Evolution of Digital Submissions

Session Chair(s)

Dalia  Fouad

Dalia Fouad

Middle East Region Head - Global Regulatory Affairs, Sanofi Aventis, United Arab Emirates

In this session, we will navigate through the lesson' learned from the implementation of eCTD in the Middle East region, while exploring the future of regulatory submission through digital transformation. From the new Continental IMS in Africa to the transition to cloud technology, this session promises to be an exciting moment to look into the future and how to support all stakeholders in their digital transformation efforts.

Speaker(s)

Ralph  Lee

A Vision for Digitalisation in the MENA region

SM Lead: Türkiye & CauCAR Clusters, Pfizer , United Kingdom

Ralph  Lee

Regional Deep-Dive: Where are we now?

SM Lead: Türkiye & CauCAR Clusters, Pfizer , United Kingdom

Assmaa  Yousry

Regional Deep-Dive: Where are we now?

PPMA Quality Assurance Unit Manager & Senior Pharmacist - PPMA, Egyptian Drug Authority (EDA), Egypt

Sana  Dabbech

Regional Deep-Dive: Where are we now?

Pharmacist - LNCM/ ANMPS, Ministry of Public Health, Tunisia

Chimwemwe  Chamdimba

New Continental IMS Working Group Africa – How is the system being set? How are learnings from other regions being utilised?

Principal Programme Officer-African Medicines Regulatory Harmonisation Program, African Union Development Agency-NEPAD, South Africa

Sara  Shatat

Update on ICH M4Q/R2

Head - General Administration of Innovative Products, Egyptian Drug Authority (EDA), Egypt

Fabio  Bisordi, MSC

Regulatory Innovation: Strengthening collaboration through cloud-based platforms to accelerate medicines to patients

Global Head International Regulatory Policy, F. Hoffmann-La Roche Ltd, Switzerland

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.